SEC Form 4 · accession 0001104659-16-137596
CATABASIS PHARMACEUTICALS INC · CATB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jean George
Director
Period of report
Aug 3, 2016
Accepted (ET)
Aug 5, 2016 · 4:08 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001454789
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $4.55 | Aug 3, 2016 | A | 6,500 | A | — | Aug 2, 2026 | Common Stock | 6,500 | 6,500 | D |
Explanation of responses
- F1This option was granted on August 3, 2016 and is scheduled to vest in full on June 15, 2017.